申请人:Kubota Hideki
公开号:US20090312328A1
公开(公告)日:2009-12-17
[Object] A compound that can be used as an agent for treating a disease associated with an EP1 receptor, in particular, a lower urinary tract symptom.
[Means for Solution] It was confirmed that a sulfonamide compound having an amide structure and characterized by a chemical structure in which a carbon atom in the amide bonds to the N atom in sulfonamide through lower alkylene, or a salt thereof, has a potent EP1 receptor antagonistic activity, accomplishing the present invention.
Since the sulfonamide compound of the present invention or a pharmaceutically acceptable salt thereof has a potent EP1 receptor antagonistic activity, it is useful as an agent for treating a disease associated with an EP1 receptor, in particular, a lower urinary tract symptom.
[物品] 一种化合物,可用作治疗与EP1受体相关的疾病的药剂,特别是下尿路症状的药剂。
[解决方案的手段] 确认了一种磺酰胺化合物,具有酰胺结构,其化学结构中的碳原子通过较低的烷基与磺酰胺中的N原子结合,或其盐,具有强大的EP1受体拮抗活性,从而实现了本发明。由于本发明的磺酰胺化合物或其药学上可接受的盐具有强大的EP1受体拮抗活性,因此它可用作治疗与EP1受体相关的疾病的药剂,特别是下尿路症状的药剂。